Enavate Sciences GP, LLC — SEC Form 4 filings

SEC reporting owner CIK 1953107. 2 Form 4 filings on record with FilingPulse; latest filed 2024-10-17.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2024-09-18 to 2024-10-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Zenas BioPharma, Inc. (ZBIO)10% owner11 leg · 882,353 sh · $15,000,0013
Camp4 Therapeutics Corp (CAMP)10% owner11 leg · 1,363,636 sh · $14,999,9962

Form 4 filings — Enavate Sciences GP, LLC

FiledFormIssuerReported transactionsSource
2024-10-174Camp4 Therapeutics Corp (CAMP)
jointly with Everest Aggregator, LP
Conversion (C): 2,422,166 · Purchase (P): 1,363,636 @ $11 · Conversion (C): 27,166,530 (derivative)EDGAR
2024-09-184Zenas BioPharma, Inc. (ZBIO)
jointly with Zebra Aggregator, LP
Conversion (C): 2,879,006 · Purchase (P): 882,353 @ $17 · Conversion (C): 10,474,889 (derivative) · Conversion (C): 14,523,821 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1953107 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →